RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis
Abstract Background Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease characterized by upregulation of inflammatory cell death and osteoclastogenesis. Necrostatin (NST)-1s is a chemical inhibitor of receptor-interacting serine/threonine-protein kinase (RIPK)1, which plays a ro...
Main Authors: | Jooyeon Jhun, Seung Hoon Lee, Se-Young Kim, Jaeyoon Ryu, Ji Ye Kwon, Hyun Sik Na, KyoungAh Jung, Su-Jin Moon, Mi-La Cho, Jun-Ki Min |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-03-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12967-019-1809-3 |
Similar Items
-
Necrostatin-1: a promising compound for neurological disorders
by: Ke-qian Chen, et al.
Published: (2024-06-01) -
RIPK1 Regulates Microglial Activation in Lipopolysaccharide-Induced Neuroinflammation and MPTP-Induced Parkinson’s Disease Mouse Models
by: Do-Yeon Kim, et al.
Published: (2023-01-01) -
Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis
by: Chen F, et al.
Published: (2017-07-01) -
Effect of necrostatin-1 on sciatic nerve crush injury in rat models
by: Chen Yu, et al.
Published: (2023-01-01) -
Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression
by: Yichun Ning, et al.
Published: (2018-04-01)